LFST (LifeStance Health Group) 5-Year EBITDA Growth Rate: 0.00% (As of Mar. 2026)


LFST LifeStance Health Group Inc LFST
56 GF Score
Price $11.27
GF Value $8.25
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is LifeStance Health Group 5-Year EBITDA Growth Rate?

LifeStance Health Group LFST -1.49% 56 5-Year EBITDA Growth Rate is 0.00% as of Mar. 2026. GuruFocus rates LFST with a GF Score™ of 56/100 and a GF Value™ of $8.25 (Significantly Overvalued). The stock has 5 warning signs investors should review.

LifeStance Health Group's EBITDA per Share for the three months ended in Mar. 2026 was $0.09.

During the past 12 months, LifeStance Health Group's average EBITDA Per Share Growth Rate was 99.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

LifeStance Health Group  (NAS:LFST) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

LifeStance Health Group 5-Year EBITDA Growth Rate Related Terms

LFST vs CON, BKD, OPCH: 5-Year EBITDA Growth Rate Comparison

For the Medical Care Facilities subindustry, LifeStance Health Group's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LifeStance Health Group 5-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, LifeStance Health Group's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where LifeStance Health Group's 5-Year EBITDA Growth Rate falls into.


LFST
56GF Score
LifeStance Health Group Inc LFST
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LifeStance Health Group 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 0.00% mean?
LifeStance Health Group (LFST) has a 5-Year EBITDA Growth Rate of 0.00% as of Mar. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for LifeStance Health Group and its competitors.
Is LifeStance Health Group's 5-Year EBITDA Growth Rate too high?
LifeStance Health Group's current 5-Year EBITDA Growth Rate is 0.00%. Overall, LifeStance Health Group has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LifeStance Health Group's 5-Year EBITDA Growth Rate compare to CON and BKD?
LifeStance Health Group's 5-Year EBITDA Growth Rate of 0.00% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
A good 5-Year EBITDA Growth Rate depends on the Healthcare Providers & Services industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for LifeStance Health Group and its competitors. LifeStance Health Group's current 5-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeStance Health Group stock overvalued right now?
Based on GuruFocus' analysis, LifeStance Health Group (LFST) is currently considered Significantly Overvalued. The stock's GF Value™ is $8.25, compared to a current price of $11.27 — trading 36.6% above its estimated fair value. The current 5-Year EBITDA Growth Rate is 0.00%. LifeStance Health Group's overall GF Score™ is 56/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For LifeStance Health Group (LFST), the current 5-Year EBITDA Growth Rate is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is LifeStance Health Group (LFST) Overvalued in 2026?

Based on GuruFocus' analysis, LifeStance Health Group stock appears to be overvalued. The current stock price of $11.27 is trading 36.6% above its estimated GF Value™ of $8.25. GuruFocus considers LifeStance Health Group to be Significantly Overvalued.

Key valuation signals for LFST:

  • 5-Year EBITDA Growth Rate: 0.00%
  • GF Value™: $8.25 vs. price of $11.27 (36.6% above fair value)
  • GF Score™: 56/100 with 5 warning signs

No single metric tells the full story. See the LFST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

LifeStance Health Group Business Description

Address 4800 North Scottsdale Road, Suite 2500, Scottsdale, AZ, USA, 85251
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
56GF Score

Get the complete analysis for LFST

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.27
Price
$8.25
GF Value